Philip Morris International Acquires Inhaled Drug Developer OtiTop
Philip Morris International Inc. (PMI) (NYSE: PM) has acquired OtiTopic, a Los Angeles-headquartered respiratory drug development company. The financial terms of the transaction were not disclosed.
